These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 37726544
1. Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants. Moore SS, De Carvalho Nunes G, Dancea A, Wutthigate P, Simoneau J, Beltempo M, Sant'Anna G, Altit G. Pediatr Res; 2024 Jan; 95(1):293-301. PubMed ID: 37726544 [Abstract] [Full Text] [Related]
2. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants]. Chen C, Huang P, Lin BC, Chen XY, Zhao J, Sun HY, Yu YL, Chen S, Qiu XM, Yang CZ. Zhonghua Er Ke Za Zhi; 2020 Sep 02; 58(9):747-752. PubMed ID: 32872715 [Abstract] [Full Text] [Related]
3. Echocardiography Assessment of Left Ventricular Function in Extremely Preterm Infants, Born at Less Than 28 Weeks' Gestation, With Bronchopulmonary Dysplasia and Systemic Hypertension. Reyes-Hernandez ME, Bischoff AR, Giesinger RE, Rios DR, Stanford AH, McNamara PJ. J Am Soc Echocardiogr; 2024 Feb 02; 37(2):237-247. PubMed ID: 37619910 [Abstract] [Full Text] [Related]
4. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH. Am J Respir Crit Care Med; 2015 Jan 01; 191(1):87-95. PubMed ID: 25389562 [Abstract] [Full Text] [Related]
5. Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy. Arjaans S, Zwart EAH, Roofthooft M, Kooi EMW, Bos AF, Berger RMF. Eur J Pediatr; 2021 Jun 01; 180(6):1855-1865. PubMed ID: 33528615 [Abstract] [Full Text] [Related]
10. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia. König K, Guy KJ, Nold-Petry CA, Barfield CP, Walsh G, Drew SM, Veldman A, Nold MF, Casalaz DM. Am J Physiol Lung Cell Mol Physiol; 2016 Dec 01; 311(6):L1076-L1081. PubMed ID: 27760764 [Abstract] [Full Text] [Related]
11. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. Nakanishi H, Uchiyama A, Kusuda S. J Perinatol; 2016 Oct 01; 36(10):890-6. PubMed ID: 27442157 [Abstract] [Full Text] [Related]
17. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study. Thomas SR, Jain SK, Murthy P, Joseph CJ, Soraisham A, Tang S, Dosani A, Lodha A. Am J Perinatol; 2024 May 01; 41(S 01):e2505-e2513. PubMed ID: 37399847 [Abstract] [Full Text] [Related]
19. Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks' gestation: an observational cohort study. Notz L, Adams M, Bassler D, Boos V. BMC Pediatr; 2024 Sep 28; 24(1):605. PubMed ID: 39342228 [Abstract] [Full Text] [Related]